GlassScriptPhysician profile
Paul C Liu
NPI 1386634236
$15,146.14
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $13K · 2021: $127 · 2022: $2,154.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,422.39 | 2020-2022 | |
| Biom'Up France Sas | $404.98 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $128.07 | 2019 | |
| Covidien LP | $119.16 | 2019 | |
| Merck Sharp & Dohme LLC | $23.09 | 2019 | |
| Tesaro, INC. | $19.48 | 2019 | |
| Genentech USA, INC. | $16.18 | 2019 | |
| Clovis Oncology, INC. | $12.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.